Boston Net Income Applicable To Common Shares from 2010 to 2026
| BSX Stock | EUR 63.80 0.80 1.24% |
Net Income Applicable To Common Shares | First Reported 2016-12-31 | Previous Quarter 504 M | Current Value 504 M | Quarterly Volatility 756.8 M |
Check Boston Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boston Scientific's main balance sheet or income statement drivers, such as Interest Expense of 245.6 M, Selling General Administrative of 4.3 B or Total Revenue of 11.8 B, as well as many indicators such as Price To Sales Ratio of 4.79, Dividend Yield of 4.0E-4 or PTB Ratio of 5.91. Boston financial statements analysis is a perfect complement when working with Boston Scientific Valuation or Volatility modules.
Boston | Net Income Applicable To Common Shares |
The Net Income Applicable To Common Shares trend for Boston Scientific offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Boston Scientific is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Boston Scientific's Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Boston Scientific over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Boston Scientific's Net Income Applicable To Common Shares historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Boston Scientific's overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Boston Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | 617,479,085 | |
| Coefficient Of Variation | 191.51 | |
| Mean Deviation | 712,389,619 | |
| Median | 347,000,000 | |
| Standard Deviation | 1,182,554,846 | |
| Sample Variance | 1398436T | |
| Range | 4.9B | |
| R-Value | 0.35 | |
| Mean Square Error | 1308172T | |
| R-Squared | 0.12 | |
| Significance | 0.17 | |
| Slope | 82,134,450 | |
| Total Sum of Squares | 22374975.4T |
Boston Net Income Applicable To Common Shares History
About Boston Scientific Financial Statements
Boston Scientific stakeholders use historical fundamental indicators, such as Boston Scientific's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Boston Scientific investors may analyze each financial statement separately, they are all interrelated. For example, changes in Boston Scientific's assets and liabilities are reflected in the revenues and expenses on Boston Scientific's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Boston Scientific. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Income Applicable To Common Shares | 738.3 M | 974.8 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Boston Stock
Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.